Ads
related to: vioxx drug
Search results
Are drugs promoted on TV ads better than others? No, study finds. Sometimes they're worse.
USA TODAY via Yahoo News· 1 year agoThey often start with someone in late-middle-age, gray-haired but active, taking a brisk hike, biking or looking out to sea. There's a passing reference to some dreaded disease the person would ...
Top FDA official Woodcock to retire early next year
BioPharma Dive via Yahoo Finance· 5 months agoThe 37-year veteran helmed the agency’s pandemic response, and was a key decision-maker in controversial calls on opioids, an Alzheimer's therapy and...
Big Pharma Is Hijacking the Information Doctors Need Most
Time via Yahoo News· 2 years agoBack in 1982, when I first began my career as a family practitioner in a small town of Boston, I was...
Merck's CEO to succeed Ken Frazier as chairman
Reuters via Yahoo Finance· 1 year agoFrazier, who has been a key growth driver of the drugmaker for decades, joined Merck around 30 years ago and became the first Black CEO of a major drug...
GSK, Sanofi and Haleon shares slump on Zantac litigation concerns
Reuters via Yahoo Finance· 2 years agoLONDON (Reuters) -Shares in GSK, Sanofi and Haleon fell sharply on Thursday, following declines...
These Antibiotics Linked To Bobby Caldwell’s Death Can Cause Disabling And Permanent Side Effects
BuzzFeed News via Yahoo News· 1 year agoR&B singer Bobby Caldwell died this week, apparently after having severe complications related to...
GSK, Sanofi shares soar as Zantac litigation fears abate
Reuters via Yahoo Finance· 1 year agoShares of GSK and Sanofi surged on Wednesday, adding more than $20 billion in combined value in...
Drugmakers' shares stabilise after Zantac litigation slump
Reuters via Yahoo Finance· 2 years agoShares in GSK, Sanofi, Haleon and Pfizer began to recover on Friday after the companies said that...
Haleon believes it is not liable for any potential Zantac liabilities
Reuters via Yahoo Finance· 2 years agoLONDON (Reuters) -Haleon believes it is not liable for any claims that may arise from U.S....
New GSK maintains strong start, but Zantac litigation looms large
Reuters via Yahoo Finance· 1 year ago(Reuters) -GSK raised its 2022 forecast for the second time this year, after third-quarter earnings...
